What Next: TBD | Tech, power, and the future
Technology
The diabetes medication Ozempic has exploded in popularity, particularly amongst those in Hollywood looking to lose a few extra pounds. But a silver bullet for weight loss leads to a number of questions: Is “buying weight loss” via injection somehow worse than diet and exercise? Are so many people buying and using this drug that people who need it for its intended purpose are missing out? What happened to body positivity?
Guest: Matthew Schneier, feature writer for New York Magazine.
Host: Lizzie O’Leary
If you enjoy this show, please consider signing up for Slate Plus. Slate Plus members get benefits like zero ads on any Slate podcast, bonus episodes of shows like Slow Burn and Dear Prudence—and you’ll be supporting the work we do here on What Next TBD. Sign up now at slate.com/whatnextplus to help support our work.
Learn more about your ad choices. Visit megaphone.fm/adchoices
Smart City: Dumb Idea?
Europe Is Burning
Silicon Valley's Hidden Discrimination
Can Twitter Sue Elon Musk Into Submission?
Paxlovid's Mysteries
Can FEMA Keep Up With Climate Change?
The Good Hackers
TikTok’s Mental Health Influencers
Does Crypto Investment Need to Be Regulated?
Can the Law Keep Up With the Internet?
From the Vault: It's Hot. It's Flooding. Is This the New Normal?
The Culture War Over Electric Cars
Sheryl Sandberg’s Complicated Legacy
Bots! What Are They Good For?
Is Elon Musk Any Good at Business?
Can an Algorithm Spot a Shooter?
Online Privacy in a Post-Roe World
Will Bitcoin Ruin El Salvador?
North Korea's Hacking Army
How Buffalo Could Transform Social Media
Create your
podcast in
minutes
It is Free
Slow Burn
Slate Debates
What Next | Daily News and Analysis
Decoder Ring
Amicus With Dahlia Lithwick | Law, justice, and the courts